Diffuse Midline Glioma H3 K27M-Mutant Latest Advances
Find the Latest Research About Diffuse Midline Glioma H3 K27M-Mutant
Last Updated: 06/30/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 708 publications
Focused ultrasound in pediatric neuro-oncology: Current applications and future directions.
Journal: Neuro-oncology advances
Published: June 12, 2026
Targeting Activin Receptor-like Kinase 2 Using Heterobifunctional Protein Degraders.
Journal: Journal of medicinal chemistry
Published: May 04, 2026
A new hope: Clinical advances in targeted therapies for pediatric diffuse midline glioma.
Journal: Neuro-oncology advances
Published: April 30, 2026
Efficacy of chemoradiotherapy in pediatric H3K27M-mutant diffuse intrinsic pontine glioma: a study based on single-center and SEER data.
Journal: Journal of neuro-oncology
Published: April 16, 2026
Intrinsic pontine tumors: Pathology of brainstem tumors and exploration of diffuse intrinsic pontine glioma.
Journal: Handbook of clinical neurology
Published: March 27, 2026
Tumor inflammation-associated neurotoxicity in children with diffuse intrinsic pontine glioma receiving B7-H3-targeting CAR T cells on BrainChild-03.
Journal: Neuro-oncology practice
Published: March 09, 2026
Inhibition of GPR68 induces ferroptosis in diffuse intrinsic pontine gliomas.
Journal: Frontiers in oncology
Published: February 11, 2026
Dysregulation of human ClpP using small molecules with piperazine-based scaffold for diffuse intrinsic pontine glioma therapy validated by patient-derived tumor organoids.
Journal: Research square
Published: February 06, 2026
Last Updated: 06/30/2026